
Evonik Invests £68m in New Facility to Expand Lipid Nanoparticle Drug Manufacturing
Evonik is investing more than CAD$150 million (€93 million/around £68 million) in a new pharmaceutical manufacturing facility in Canada as it prepares for growing demand for lipid nanoparticle-based medicines. The new GMP facility in Vancouver […]



